Abstract:Background Sarcopenia is an age‐related muscle disease that increases the risk of falls, disabilities, and death. It is associated with increased muscle protein degradation driven by molecular signalling pathways including Akt and FOXO1. This study aims to identify genes, gene interactions, and molecular pathways and processes associated with muscle aging and exercise in older adults that remained undiscovered until now leveraging on an artificial intelligence approach called artificial neural network inference (ANNi). Methods Four datasets reporting the profile of muscle transcriptome obtained by RNA‐seq of young (21–43 years) and older adults (63–79 years) were selected and retrieved from the Gene Expression Omnibus (GEO) data repository. Two datasets contained the transcriptome profiles associated to muscle aging and two the transcriptome linked to resistant exercise in older adults, the latter before and after 6 months of exercise training. Each dataset was individually analysed by ANNi based on a swarm neural network approach integrated into a deep learning model (Intelligent Omics). This allowed us to identify top 200 genes influencing (drivers) or being influenced (targets) by aging or exercise and the strongest interactions between such genes. Downstream gene ontology (GO) analysis of these 200 genes was performed using Metacore (ClarivateTM) and the open‐source software, Metascape. To confirm the differential expression of the genes showing the strongest interactions, real‐time quantitative PCR (RT‐qPCR) was employed on human muscle biopsies obtained from eight young (25 ± 4 years) and eight older men (78 ± 7.6 years), partaking in a 6‐month resistance exercise training programme. Results CHAD, ZDBF2, USP54, and JAK2 were identified as the genes with the strongest interactions predicting aging, while SCFD1, KDM5D, EIF4A2, and NIPAL3 were the main interacting genes associated with long‐term exercise in older adults. RT‐qPCR confirmed significant upregulation of USP54 (P = 0.005), CHAD (P = 0.03), and ZDBF2 (P = 0.008) in the aging muscle, while exercise‐related genes were not differentially expressed (EIF4A2 P = 0.99, NIPAL3 P = 0.94, SCFD1 P = 0.94, and KDM5D P = 0.64). GO analysis related to skeletal muscle aging suggests enrichment of pathways linked to bone development (adj P‐value 0.006), immune response (adj P‐value <0.001), and apoptosis (adj P‐value 0.01). In older exercising adults, these were ECM remodelling (adj P‐value <0.001), protein folding (adj P‐value <0.001), and proteolysis (adj P‐value <0.001). Conclusions Using ANNi and RT‐qPCR, we identified three strongly interacting genes predicting muscle aging, ZDBF2, USP54, and CHAD. These findings can help to inform the design of nonpharmacological and pharmacological interventions that prevent or mitigate sarcopenia.

Identification of nicotinamide N‐methyltransferase as a promising therapeutic target for sarcopenia

Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice

Integrated Multi-Omics Analysis Identifies Disrupted Branched-Chain Amino Acid Catabolism As Causal for Sarcopenia

Novel metabolic and lipidomic biomarkers of sarcopenia

Reduced energy metabolism contributing to aging of skeletal muscle by serum metabolomics and gut microbiota analysis

Identification of Novel Pathways and Immune Profiles Related to Sarcopenia

Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and health span in C. elegans

Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions

Single nuclei profiling identifies cell specific markers of skeletal muscle aging, sarcopenia and senescence

Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia

Identification of key genes and signaling pathways based on transcriptomic studies of aerobic and resistance training interventions in sarcopenia in SAMP8 mice

Nicotinamide Protects Against Skeletal Muscle Atrophy in Streptozotocin-Induced Diabetic Mice

Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle

Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models

AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions

Cross-Species Studies Reveal That Dysregulated Mitochondrial Gene Expression and Electron Transport Complex I Activity Are Crucial for Sarcopenia

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology

Proteome network analysis of skeletal muscle in lignan-enriched nutmeg extract-fed aged mice

Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function

Artificial neural network inference analysis identified novel genes and gene interactions associated with skeletal muscle aging

AAV1.NT-3 gene therapy prevents age-related sarcopenia